Related Experiment Video
Updated: Jul 22, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Venom immunotherapy: when to start, when to stop
1Asthma and Allergic Diseases, Park Nicollet Clinic, Minneapolis, Minnesota 55416-2699, USA.
Abstract:
Over the past 25 years, major advances have been made in the diagnosis and treatment of insect sting allergy. Controlled clinical trials have demonstrated the efficacy of venom immunotherapy (VIT) in the prevention of subsequent systemic reactions in allergic individuals. We have refined our criteria for selection of patients for VIT. Studies on selections of venoms, rush immunotherapy, and interval between VIT injections have been performed. Finally, much work has been done to try to define criteria for the discontinuation of VIT.
Related Concept Videos
Prevention of Further Absorption of Poison
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Allergic Reactions: Anaphylaxis
Pharmaceutical Poisoning: Treatment Strategies

